Polycystic ovary syndrome: the new millenium

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Molecular and Cellular Endocrinology

• Publication date

  2001-11-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0303-7207(01)00640-2PMID 11694344
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial.

  2001cited by this paper
• Women with polycystic ovary syndrome gain regular menstrual cycles when ageing.

  2000cited by this paper
• Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome.

  2000cited by this paper
• Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome.

  2000cited by this paper
• Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome

  2000cited by this paper
• Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.

  2000cited by this paper
• Women with polycystic ovary syndrome gain regular menstrual cycles when ageing

  2000cited by this paper
• Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.

  2000cited by this paper
• Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

  2000cited by this paper
• Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.

  2000cited by this paper
• Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

  1999cited by this paper
• Insulin-lowering therapeutic modalities for polycystic ovary syndrome.

  1999cited by this paper
• Polycystic ovary syndrome. Phenotype to genotype.

  1999cited by this paper
• Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.

  1999cited by this paper
• Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.

  1999cited by this paper
• The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long‐term oestrogen–progestagen treatment

  1999cited by this paper
• Use of oral contraceptives and endometrial cancer risk (Sweden)

  1999cited by this paper
• Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.

  1999cited by this paper
• A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

  1999cited by this paper
• Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin.

  1999cited by this paper
• Mortality of women with polycystic ovary syndrome at long-term follow-up.

  1998cited by this paper
• Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study.

  1998cited by this paper
• Results of gonadotrophin stimulation with the option to convert cycles to in vitro fertilization in cases ofmultifollicular development

  1998cited by this paper
• The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome.

  1998cited by this paper
• Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism.

  1997cited by this paper
• Insulin regulation of human ovarian androgens.

  1997cited by this paper
• Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

  1997cited by this paper
• The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome.

  1997cited by this paper
• Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome.

  1997cited by this paper
• Menstrual Cyclicity After Metformin Therapy in Polycystic Ovary Syndrome

  1997cited by this paper
• Epithelial Ovarian Cancer Risk Among Women With Polycystic Ovary Syndrome

  1996cited by this paper
• Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study.

  1996cited by this paper
• Treatment of anovulatory infertility: the problem of multiple pregnancy.

  1996cited by this paper
• Polycystic ovary syndrome: pathophysiology and outcome with in vitro fertilization.

  1996cited by this paper
• Gonadotrophin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomiphene-resistant polycystic ovarian syndrome.

  1996cited by this paper
• Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome.

  1996cited by this paper
• Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.

  1995cited by this paper
• Endometrial and ovarian cancer and oral contraceptives--findings in a large cohort study.

  1995cited by this paper
• Evidence that an altered prolactin release is consequent to abnormal ovarian activity in polycystic ovary syndrome.

  1995cited by this paper
• Surgically induced ovulation in the polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy.

  1995cited by this paper
• Polycystic ovary syndrome.

  1995cited by this paper
• The Prevalence of Polycystic Ovaries on Ultrasound Scanning in a Population of Randomly Selected Women

  1994cited by this paper
• Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients.

  1994cited by this paper
• Native gonadotropin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction.

  1994cited by this paper
• Abnormal production of androgens in women with breast cancer.

  1994cited by this paper
• Recency, duration, and progestin content of oral contraceptives in relation to the incidence of endometrial cancer (Washington, USA)

  1994cited by this paper
• Prevalence of and Etiological Factors in Polycystic Ovarian Syndrome

  1993cited by this paper
• Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?

  1992cited by this paper
• Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones.

  1992cited by this paper
• Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study.

  1992cited by this paper
• Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome.

  1992cited by this paper
• Polycystic ovary syndrome.

  1992cited by this paper
• Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome

  1992cited by this paper
• Polycystic ovaries and the risk of breast cancer.

  1991cited by this paper
• Hirsutism in Polycystic Ovary Syndrome: Current Concepts

  1991cited by this paper
• Serum and urinary androgens and risk of breast cancer in postmenopausal women.

  1991cited by this paper
• High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study.

  1990cited by this paper
• A Model For Prediction Of Endometrial Cancer

  1989cited by this paper
• Banting lecture 1988. Role of insulin resistance in human disease.

  1988cited by this paper
• High density lipoprotein cholesterol and mortality. The Framingham Heart Study.

  1988cited by this paper
• Polycystic ovaries--a common finding in normal women.

  1988cited by this paper
• Role of Insulin Resistance in Human Disease

  1988cited by this paper
• Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization.

  1988cited by this paper
• Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies.

  1987cited by this paper
• Ovulation induction with gonadotropin-releasing hormone.

  1985cited by this paper
• Objective assessment of treatment response in hirsutism.

  1985cited by this paper
• Increased 5 alpha-reductase activity in idiopathic hirsutism.

  1985cited by this paper
• Increased 5α-reductase activity in idiopathic hirsutism*†

  1985cited by this paper
• Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.

  1983cited by this paper
• Chronic Anovulation Syndrome and Associated Neoplasia

  1983cited by this paper
• Protection against endometrial carcinoma by combination-product oral contraceptives.

  1982cited by this paper
• Hirsutism: implications, etiology, and management.

  1981cited by this paper
• The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease.

  1980cited by this paper
• Comparison of effects of different combined oral-contraceptive formulations on carbohydrate and lipid metabolism.

  1979cited by this paper
• Letter: Kumidini hospital.

  1975cited by this paper
• CLINICAL AND BIOCHEMICAL FEATURES OF POLYCYSTIC OVARIAN DISEASE.

  1963cited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study*

  year unknowncited by this paper

• Using Machine Learning to Construct the Blood-Follicle Distribution Models of Various Trace Elements and Explore the Transport-Related Pathways with Multiomics Data.

  2024cites this paper
• The Female Athlete Triad/Relative Energy Deficiency in Sports

  2022cites this paper
• Efficacy of Spironolactone in Adult Acne in Polycystic Ovary Syndrome Patients an Original Research

  2021cites this paper
• Clinical, Hormonal, and Metabolic Parameters in Women with Subclinical Hypothyroidism and Polycystic Ovary Syndrome: A Cross-Sectional Study

  2018cites this paper
• Abnormal irisin level in serum and endometrium is associated with metabolic dysfunction in polycystic ovary syndrome patients

  2018cites this paper
• Polycystic Ovary Syndrome, Pathophysiology, and Reproductive Health Implications

  2018cites this paper
• Polycystic Ovary Syndrome (PCOS), Diagnostic Criteria, and AMH

  2017cites this paper
• Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3‐iodothyronamine

  2017cites this paper
• Polikistik over sendromunda over volümü ölçümü ve metabolik değerlendirme: kesitsel gözlemsel çalişma Metabolic evaluation and measurement of ovarian volume in polycystic ovary sydrome: a cross-sectional observational study

  2016cites this paper
• Polikistik over sendromunda over volümü ölçümü ve metabolik değerlendirme: kesitsel gözlemsel çalışma

  2016cites this paper
• Long-Term High Fat Diet Has a Profound Effect on Body Weight, Hormone Levels, and Estrous Cycle in Mice

  2016cites this paper
• Permselectivity of Blood-Follicle Barriers in Mouse Polycystic Ovary Model

  2016cites this paper
• Effects of metformin on the adrenal cortex of androgenized rats

  2015cites this paper
• Naloxone affects reproductive system in a rat model with polycystic features

  2015cites this paper
• A Study on Management of An ovulatory Infertility in Urban Nepalese Population

  2015cites this paper
• RUNX2, GPX3 and PTX3 gene expression profiling in cumulus cells are reflective oocyte/embryo competence and potentially reliable predictors of embryo developmental competence in PCOS patients

  2013cites this paper
• Copper sulfate inhibits seizure activity induced by pentylenetetrazole in mice

  2013cites this paper
• Differences in the transcriptional profiles of human cumulus cells isolated from MI and MII oocytes of patients with polycystic ovary syndrome.

  2013cites this paper
• The blood-follicle barrier (BFB) in disease and in ovarian function.

  2012cites this paper
• The Effect of Flutamide on Ovulation Induction in PCOS Patients

  2012cites this paper
• Automated screening of Polycystic Ovary Syndrome using machine learning techniques

  2011cites this paper
• The effect of insulin signaling on female reproductive function independent of adiposity and hyperglycemia.

  2010cites this paper
• Ultrasound and its role in assisted reproduction treatment

  2010cites this paper
• Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence

  2010cites this paper
• Polimorfismos do gene da adiponectina e variáveis clínicas, metabólicas e hormonais em mulheres com ou sem a síndrome dos ovários policísticos (PCOS) e investigação de um modelo animal para o estudo da PCOS

  2010cites this paper
• Food and Western Disease Health and Nutrition from an Evolutionary Perspective

  2009cites this paper
• CHAPTER 13 – Reproductive Immunology and Its Disorders

  2009cites this paper
• PDE8A genetic variation, polycystic ovary syndrome and androgen levels in women.

  2009cites this paper
• Botanical Treatment for Polycystic Ovary Syndrome

  2009cites this paper
• Women with polycystic ovary syndrome are often depressed or anxious--a case control study.

  2008cites this paper
• Polycystic Ovarian Disease

  2008cites this paper
• Current evaluation of amenorrhea.

  2008cites this paper
• Permselectivity of blood follicle barriers in mouse ovaries of the mifepristone-induced polycystic ovary model revealed by in vivo cryotechnique.

  2008cites this paper
• Genomics and Polycystic Ovary Syndrome (PCOS): The Use of Microarray Analysis to Identify New Candidate Genes

  2008cites this paper
• Relation of nutrients and hormones in polycystic ovary syndrome.

  2007cites this paper
• Morphological and Morphometric Analysis of the Adrenal Cortex of Androgenized Female Rats

  2007cites this paper
• Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis.

  2007cites this paper
• Best practice in primary care pathology: review 11

  2007cites this paper
• Deregulation of tissue homeostasis in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia.

  2007cites this paper
• The management of insulin resistance in polycystic ovary syndrome.

  2007cites this paper
• Best practice in primary care pathology: review 4

  2006cites this paper
• The Practice Committee of the American Society for Reproductive Medicine and the Practice Committee of the Society for Assisted Reproductive Technology

  2006cites this paper
• Serum Adiponectin, TNF-α, IL-6 and Insulin Resistance in Women with Polycystic Ovary Syndrome

  2006cites this paper
• Estrogenic ovulatory dysfunction or functional female hyperandrogenism: an argument to discard the term polycystic ovary syndrome.

  2006cites this paper
• Chapter 6 The adipocyte and adipose tissue as endocrine organs: Impact on the insulin resistance phenotype

  2006cites this paper
• Current evaluation of amenorrhea.

  2006cites this paper
• Spironolactone in the treatment of polycystic ovary syndrome: Effects on clinical features, insulin sensitivity and lipid profile

  2005cites this paper
• Influence of Leptin, Androgens and Insulin Sensitivity on Increased GH Response to Clonidine in Lean Patients with Polycystic Ovary Syndrome

  2005cites this paper
• Endocrine–metabolic effects of the treatment with pioglitazonein obese patients with polycystic ovary syndrome

  2005cites this paper
• Increased growth hormone response to clonidine in nonobese normoinsulinemic patients with polycystic ovary syndrome.

  2004cites this paper
• Current evaluation of amenorrhea.

  2004cites this paper
• Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome.

  2004influential citation
• Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: A case of idiopathic hirsutism?

  2004cites this paper
• Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome?

  2004cites this paper
• Long-term reproductive endocrine health in young women with epilepsy during puberty

  2004cites this paper
• Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome.

  2004cites this paper
• Acute and "chronic" phase reaction-a mother of disease.

  2004cites this paper
• Current evaluation of amenorrhea.

  2004cites this paper
• Lack of an Association between Peroxisome Proliferator-Activated Receptor-γ Gene Pro12Ala Polymorphism and Adiponectin Levels in the Polycystic Ovary Syndrome

  2004cites this paper
• Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel.

  2003cites this paper
• Expression of steroid receptors and proteins related to apoptosis in endometria of women with polycystic ovary syndrome.

  2003cites this paper
• Adiponectin levels in women with polycystic ovary syndrome.

  2003cites this paper
• Handbook of Diagnostic Endocrinology

  2003cites this paper
• Genetic and environmental aspect of polycystic ovary syndrome

  2003cites this paper
• Circulating ghrelin concentrations in the polycystic ovary syndrome.

  2003cites this paper
• Treatment of the Infertile Patient With Polycystic Ovarian Syndrome

  2002cites this paper
• Genetic analysis of candidate genes for the polycystic ovary syndrome

  2002cites this paper
• Treatment of acne vulgaris.

  1958cites this paper
• Reproductive Biology and Endocrinology Open Access Potential Action of Androstenedione on the Proliferation and Apoptosis of Stromal Endometrial Cells

  year unknowncites this paper